Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Incyte Stock (NASDAQ: INCY) stock price, news, charts, stock research, profile.
Open | $63.52 |
Close | $64.14 |
Volume / Avg. | 1.57M / 3.43M |
Day Range | $63.05 - $64.46 |
52 Wk Range | 50.27 - 70.36 |
Market Cap | $12.35B |
P/E Ratio | 153.71 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 11.22% |
Days to Cover | 5.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Incyte (NASDAQ:INCY) through any online brokerage.
Other companies in Incyte’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
Incyte has a consensus price target of $75.24.
The stock price for Incyte (NASDAQ: INCY) is $64.14 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Incyte.
Incyte’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
There is no upcoming split for Incyte.
Incyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.